Curriculum, faculty, and budget of a modest PharmD program are reviewed and compared with the costs of enriching such a program. Extensive tabular data are given to support the budgeting plans. (LBH)

The AACP executive director reports on developments in pharmacy colleges in the areas of membership, communications, meetings, finances, government affairs, new projects and services, staff and facilities, student affairs, and educational research and development. (LBH)

Degrees conferred are reported in tabular form showing degrees by schools, by district, by ethnic group, and by type of degree (BS, BPharm, PharmD, master of science, PhD, and honorary). (LBH)

The issue of quality in graduate programs is discussed generally, so that programs in the pharmaceutical sciences can be viewed in the broad context of science, rather than in the narrower confines of the profession of pharmacy. Consideration is given to goals, faculty characteristics, student quality, and development procedures. (LBH)

Management strategy and policy adapted at the University of Illinois at the Medical Center are described in terms of: faculty teaching vs. research time; faculty effectiveness and productivity; committee meetings; morale; departmental funds for research; expectations from graduate students; student recruitment; and program implementation. (LBH)

Procedures followed by federal agencies upon receipt of a grant proposal are reviewed and suggestions are offered for receiving help in preparing an application and for locating sources of funds. (LBH)

Study sections are nongovernment scientists who review applications for research grants that have been assigned to the various institutes within NIH. Procedures followed by these committees in evaluating research problems are outlined. (LBH)

Aside from general teaching obligations, a major professor also has responsibilities to his students regarding the research problem, funding, time commitment and personal interaction, and the postgraduate job. (Author/LBH)

Foreign graduate students present many problems of a moral and ethical nature to U.S. universities, but if they are qualified on the basis of educational background and English language ability, they need to be accepted into American institutions. (Author/LBH)

Positive and negative influences of contract research on graduate education are reviewed, with time restrictions noted as a significant difference between contract and grant-supported research. Specific conditions are cited, which, if met, can ensure beneficial effects for graduate study. (LBH)

The majority of colleges of pharmacy consist and should continue to consist of a majority of pharmacy-educated faculty, but there are a limited though substantial proportion of academic employment opportunities in pharmacy schools for qualified scientists without pharmacy backgrounds. (Author/LBH)

A FIPSE-sponsored National Task Force on Better Information for Student Choice identified three broad areas of information needs: costs and financial aid; academic offerings and requirements; and the outcomes or results of attendance. These are discussed in terms of graduate programs within the pharmaceutical sciences. (LBH)

A rationale for defining "clinical pharmaceutical scientist" is developed along with an outline of the aims and purposes of a training program for him. Postdoctoral (PharmD) fellowships are described as the most effective training method. (LBH)

In addition to providing a larger number of investigators who can solve current problems, developing and supporting a clinical scientist training program can provide better clinicians. Specific academic and technological courses are cited along with mentor roles and time factors involved in training clinical scientists. (Author/LBH)

In determining how to allocate resources, focus must be placed on the tradeoffs between utilization of already-established courses within a college of pharmacy (or the university) and the design of a totally new group of courses for the training of clinical scientists. Most necessary courses are already available. (Author/LBH)